Trump hints at tariff grace period for pharma companies to onshore manufacturingnews2025-07-08T19:23:54+00:00July 8th, 2025|Endpoints News|
Compromised drug lot impacts Jasper’s chronic hives study, stock fallsnews2025-07-07T14:39:41+00:00July 7th, 2025|Endpoints News|
European Commission fines Alchem, closes API ‘cartel’ investigation news2025-07-07T02:05:08+00:00July 7th, 2025|Endpoints News|
Torrent Pharma’s $1.38B JB Chemicals takeover; Future Pak to buy Theratechnologiesnews2025-07-03T14:20:10+00:00July 3rd, 2025|Endpoints News|
BioSpring embarks on €100M+ nucleic acid factory in Germanynews2025-07-03T11:30:49+00:00July 3rd, 2025|Endpoints News|
Hikma pledges $1B to expand US manufacturing presencenews2025-06-30T11:12:49+00:00June 30th, 2025|Endpoints News|
Unicycive gets a CRL for chronic kidney disease pill as third-party production issues lingernews2025-06-30T11:05:19+00:00June 30th, 2025|Endpoints News|
Bharat, GSK to cut malaria vaccine price; Emergent’s US stockpile deal expandsnews2025-06-26T12:55:09+00:00June 26th, 2025|Endpoints News|
Pharma companies are weighing how a drug’s IP location could impact tariffsnews2025-06-20T15:38:49+00:00June 20th, 2025|Endpoints News|
Enzene, Veranova separately unveil expansions; Lotte’s new ADC clientnews2025-06-20T12:55:57+00:00June 20th, 2025|Endpoints News|
